化学
渗透剂(生化)
哌啶
钾通道
部分
离子通道
药物发现
组合化学
化学合成
计算生物学
神经科学
药理学
结构-活动关系
化学生物学
中枢神经系统
赫尔格
渗透(战争)
作者
Motoyuki Tanaka,Yoko Sekioka,Gakuji Hashimoto,Takahiro Mori,Tomoyuki Shono,Yuuki Isaji,Katsuya Hisaichi,Elizabeth S. Childress,Sean R. Bollinger,Joza Schmitt,Trevor C. Chopko,Aaron T. Garrison,Charles K. Perry,Keagan S. Chronister,Meghan Kramer,Sichen Chang,Katherine J. Watson,Jonathan W. Dickerson,Michael Bubser,Jerri M. Rook
标识
DOI:10.1021/acs.jmedchem.5c02535
摘要
Abstract Herein we describe the chemical optimization of a selective and CNS penetrant series of TREK inhibitors (the K2P family of potassium ion channels), culminating in the discovery of ONO-9517601 (VU6022856) and ONO-7927846 (VU6024391). Optimization of ONO-TR-772 focused on replacements for the N-Boc aniline moiety and identified N-acyl piperidine pyrazoles as attractive surrogates, affording excellent potency, PK profiles, CNS penetration and ion channel selectivity. ONO-9517601 and ONO-7927846 displayed robust efficacy in an MK-801 challenge rat NOR paradigm, with MEDs of 1 mg/kg and 0.3 mg/kg, respectively. These ligands represent valuable preclinical research tools for exploring selective TREK inhibition in vitro and in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI